98%
921
2 minutes
20
Objective: Among immunocompromised patients with acute respiratory failure, identification of those at higher risk for opportunistic infections is crucial to optimize management. The Torque teno virus (TTV) DNA burden in the blood has been identified as a surrogate marker of functional immunity in solid organ transplant recipients. This study investigates the clinical relevance of TTV DNA in nasopharyngeal swabs of immunocompromised patients with acute respiratory failure (ARF).
Methods: We enrolled immunocompromised patients with acute respiratory failure admitted to 32 ICUs. Nasopharyngeal swabs collected on admission were tested for TTV DNA. Causes of ARF were reviewed by three expert investigators blinded to TTV results, with a specific attention to the presence of opportunistic infections. The primary endpoint was the association between TTV DNA burden in nasopharyngeal swabs and the rate of opportunistic infections causing the ARF.
Results: Of the 505 patients, respiratory TTV DNA was detected in 304/505 (60%), with TTV burden≥2.9 logcopies/mL in 184/305 (36%). TTV burden≥2.9 logcopies/mL was significantly associated with a higher prevalence of opportunistic infections (20% (36/178) vs. 11% (33/307), adjusted OR 2.41, 95%CI 1.35 to 4.28; p=0.002). High TTV burden ≥2.9 logcopies/mL was also associated with a higher rate of all-cause pulmonary infections (67% (119/178) vs. 56% (108/192) when not detected), microbiologically documented bacterial infections (35% (62/178) vs. 23% (45/192)), and with a higher rate of Influenza-like respiratory virus detection in nasopharyngeal swabs (15% (27/184) vs. 6% (12/201) when not detected). Furthermore, TTV detection was associated with a higher rate of mechanical ventilation or death at day 28 (59% (179/304) vs. 48% (97/201) when not detected).
Conclusions: In immunocompromised patients with acute respiratory failure, high TTV burden in the respiratory tract is associated with higher rates of pulmonary infections due to opportunistic pathogens and with adverse outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmi.2025.07.035 | DOI Listing |
Curr Opin Infect Dis
August 2025
Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital.
Purpose Of Review: Plasma metagenomic next-generation sequencing (mNGS) enables detection of microbial cell-free deoxyribonucleic acid (mcfDNA) in blood without the need for culture or organism-specific primers. Here, we review clinical performance, methodological variability, and real-world application of plasma mNGS for infectious disease diagnosis in immunocompromised hosts (ICHs).
Recent Findings: Plasma mNGS has rapidly gained attention as a novel diagnostic tool for infections in ICHs, offering broad-range pathogen detection from a noninvasive blood sample.
Microbiol Spectr
September 2025
Department of Clinical Microbiology, Hospital Clínic of Barcelona-ISGlobal, University of Barcelona, Barcelona, Spain.
Unlabelled: Accurate methods to assess viral viability are crucial for determining isolation duration and antiviral therapy in immunocompromised patients. Although cell culture (CC) is the gold standard, it has limitations. Cycle threshold (Ct) values from genomic RNA (gRNA) RT-PCR and subgenomic RNA (sgRNA) RT-PCR have been proposed as markers of active viral replication.
View Article and Find Full Text PDFCrohns Colitis 360
July 2025
Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Introduction: Acute severe ulcerative colitis (ASUC) typically requires hospitalization for intravenous (IV) corticosteroid treatment and monitoring. In response to the need to reduce inpatient stays, especially during the COVID-19 pandemic, outpatient treatment models have gained interest. This study evaluated the feasibility, safety, and patient satisfaction of outpatient IV corticosteroid treatment for ASUC.
View Article and Find Full Text PDFCan J Infect Dis Med Microbiol
August 2025
Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
, an opportunistic protozoan parasite, poses significant risks to immunocompromised patients, including those with cancer, transplants, or on hemodialysis. The aim of this study was to determine the pooled prevalence of in immunocompromised individuals (cancer, transplant, and hemodialysis) and assess the associated risk factors compared to nonimmunocompromised controls. A comprehensive search of international databases was conducted for studies published up to October 18, 2024, focusing on cross-sectional and case-control studies that reported prevalence in immunocompromised patients.
View Article and Find Full Text PDFNew Microbes New Infect
October 2025
Biotecnopolo Foundation, Via Fiorentina 1, 53100, Siena, Italy.